Fig. 1From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneRECIST responses by chest CT scan in 3 patients with bilateral lung metastases, before gemcitabine and docetaxel (GD) treatment (a, b, c) and after 2 cycles of therapy (e, f, g); PET/CT imaging showing 18 F-FDG uptake in a patient with osteosarcoma lung metastastases, before GD treatment (d) and after 7 cycles of therapy (h)Back to article page